CILOXAN

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, France, Croatia, Ireland, Israel, Lithuania, Malta, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug CILOXAN contains one active pharmaceutical ingredient (API):

1 Ciprofloxacin
UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE

Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.

Read about Ciprofloxacin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
CILOXAN Ointment FDA, National Drug Code (US) MPI, US: SPL/Old
CILOXAN Eye drops, solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CILOXAN Ophthalmic solution FDA, National Drug Code (US) MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
S01AE03 S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AE Fluoroquinolones
Discover more medicines within S01AE03
S03AA07 Ciprofloxacin S Sensory organs → S03 Ophthalmological and otological preparations → S03A Antiinfectives → S03AA Antiinfectives
Discover more medicines within S03AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 1217C, 2480M, 5564W
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 500900801176315, 500900803179311
Country: CA Health Products and Food Branch Identifier(s): 01945270, 02200864
Country: EE Ravimiamet Identifier(s): 1042827, 1842892
Country: FR Base de données publique des médicaments Identifier(s): 67901977, 69358697, 69501024
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 144958, 161481, 186289, 36867
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-578076301
Country: IE Health Products Regulatory Authority Identifier(s): 17731
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 2782
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1012609, 1081767, 1082882, 1087567, 1088797, 1090232, 1093348
Country: MT Medicines Authority Identifier(s): MA1249/01301, MA1249/01302, PI1513/00801A, PI908/23201A
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 12961, 6703
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100079607, 100105411, 100293915
Country: SG Health Sciences Authority Identifier(s): 11265P, 11929P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 6643142
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699504440508, 8699504612035
Country: US FDA, National Drug Code Identifier(s): 0065-0654, 0065-0656
Country: ZA Health Products Regulatory Authority Identifier(s): 35/15.1/0410, Z/15.1/202

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.